Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Archives of Orthopaedic and Trauma Surgery
Published in: Archives of Orthopaedic and Trauma Surgery 1/2011

01-01-2011 | Basic Science

Viscosupplementation in the management of ankle osteoarthritis: a review

Authors: Alberto Migliore, Francesca Giovannangeli, Emanuele Bizzi, Umberto Massafra, Andrea Alimonti, Bruno Laganà, Andrea Diamanti Picchianti, Valentina Germano, Mauro Granata, Prisco Piscitelli

Published in: Archives of Orthopaedic and Trauma Surgery | Issue 1/2011

Login to get access

Abstract

Introduction

Osteoarthritis (OA) is a disease of synovial joints and is the most common cause of chronic pain. Viscosupplementation (VS) with hyaluronic acid (HA) is largely used for knee osteoarthritis therapy but the evidence for its usefulness in ankle osteoarthritis is limited. The objective of this review is to assess the efficacy of viscosupplementation treatment of ankle osteoarthritis in the current literature.

Methods

The following databases were searched: Medline (period 2006–2008), Database of Abstract on Reviews and Effectiveness and Cochrane Database of Systematic Reviews. Reference lists of relevant articles were controlled for additional references. The search terms Review, Viscosupplementation (VS), Osteoarthritis (OA), Hyaluronic acid (HA), Hyaluronan, Sodium hyaluronate, Ankle OA, Ankle joint were used to identify all studies relating to the use of VS therapy for the ankle OA. Methodological quality of included studies was assessed by assigning level of evidence as previously defined by the Centre for Evidence Based Medicine (CEBM).

Result

Seven articles concerning the efficacy of a total of 275 patients undergoing VS treatment for ankle OA were included. One European study, one Taiwanese study, one Italian study, one Turkish study and three American studies with level of evidence ranging from I to IV evaluated the following products: Hyalgan®, Synvisc®, Supartz®, Adant®.

Conclusion

Viscosupplementation is used widely in knee OA and is included in the professional guidelines for treatment of the disease in this joint. The potential for treating osteoarthritis of the ankle joint by viscosupplementation has been suggested in the literature, however, no dosing studies have been published to date, and dosing in the ankle joint remains an area for discussion. Viscosupplementation could potentially provide an useful alternative in treating such patients with painful ankle OA.
Literature
1.
Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, Kington RS, Lane NE, Nevitt MC, Zhang Y, Sowers M, McAlindon T, Spector TD, Poole AR, Yanovski SZ, Ateshian G, Sharma L, Buckwalter JA, Brandt KD, Fries JF (2000) Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 133(8):635–646 (Review)PubMed
2.
Buckwalter JA, Mankin HJ (1998) Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect 47:487–504 (Review)PubMed
3.
Ea Balazs (1982) The physical properties of synovial fluid and the special role of hyaluronic acid. Disorders of the knee. T.B. Lippincott, Philadelphia
4.
Balazs EA, Denlinger JL (1985) Sodium hyaluronate acid and joint function. J Equine Vet Sci 5:217–218CrossRef
5.
Altman D (1992) Laboratory findings in osteoarthritis. In: Moskowtz R, Howell D, Goldberg V, Mankin J (eds) Osteoarthritis-diagnosis and medical surgical management. WB Saunders, Philadelphia
6.
Balazs EA, Wason D, Huff IF, Roseman S (1967) Hyaluronic acid in synovial fluid: molecular parameters of hyaluronic acid in normal and arthritic fluids. Arthritis Rheum 10:357–376CrossRefPubMed
7.
Balazs EA, Briller S, Denlinger J (1981) Na-hyaluronate molecular size variations in equine arthritis and human arthritic synovial fluid and the effect on phagocytic cells. In: Talbot J (ed) Seminars in arthritis and rheumatism. Grune & Stratton, New York
8.
Dahl LB, Dahl IM, Enstron-Laurent A, Granath K (1985) Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 44:817–822CrossRefPubMed
9.
Larsen NE, Lombard KM, Parent EG, Balazs EA (1992) Effect of hylan on cartilage and chondrocyte cultures. J Orthop Res 10:23–32CrossRefPubMed
10.
Balazs EA, Denlinger JL (1993) Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl 39:3–9PubMed
11.
Ghosh P, Guidolin D (2002) Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthritis Rheum 32(1):10–37CrossRefPubMed
12.
Balazs EA, Denlinger JL (1984) The synovial cell. In: Scarpelli DG, Migaki G, Alan R (eds) Comparative pathobiology of mayor age-related disease: current status and research frontiers (Modern aging research 4). Liss Inc., New York
13.
Buckwalter JA, Saltzman C, Brown T (2004) The impact of osteoarthritis: implications for research. Clin Orthop Relat Res 427(Suppl):S6–S15 ReviewCrossRefPubMed
14.
Cushnaghan J, Dieppe P (1991) Study of 500 patients with limb joint osteoarthritis. I. Analysis by age, sex, and distribution of symptomatic joint sites. Ann Rheum Dis 50:8–13CrossRefPubMed
15.
Saltzman CL, Salamon ML, Blanchard GM, Huff T, Hayes A, Buckwalter JA, Amendola A (2005) Epidemiology of ankle arthritis: report of a consecutive series of 639 patients from a tertiary orthopaedic center. Iowa Orthop J 25:44–46PubMed
16.
Brown TD, Johnston RC, Saltzman CL, Marsh JL, Buckwalter JA (2006) Posttraumatic osteoarthritis: a first estimate of incidence, prevalence, and burden of disease. J Orthop Trauma 20(10):739–744CrossRefPubMed
17.
Horisberger M, Valderrabano V, Hintermann B (2009) Posttraumatic ankle osteoarthritis after ankle-related fractures. J Orthop Trauma 23(1):60–67CrossRefPubMed
18.
Van Dijk CN, Tol JL, Verheyen CC (1997) A prospective study of prognostic factors concerning the outcome of arthroscopic surgery for anterior ankle impingement. Am J Sports Med 25:737–745CrossRefPubMed
19.
American College of Rheumatology Subcommittee on Osteoarthritis Guidelines (2000) Recommendations for the medical management of osteoarthritis of the hip and the knee: 2000 update. Arthritis Rheum 43:1905–1915CrossRef
20.
Pendleton A, Arden N, Dougados M, Doherty M, Bannwarth B, Bijlsma JW et al (2000) EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies including Therapeutic Trials (ESCISIT). Ann Rheum Dis 59:936–944CrossRefPubMed
21.
Pleimann JH, Davis WH, Cohen BE et al (2002) Viscosupplementation for the arthritic ankle. Foot Ankle Clin 7(3):489–494CrossRefPubMed
22.
Wang CW, Gao LH, Jin XY et al (2002) Clinical study of sodium hyaluronate in supplementary treatment of comminuted fracture of ankle. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 16(1):21–22PubMed
23.
Gaston MS, Tiemessen CH, Philips JE (2007) Intra-articular hip viscosupplementation with synthetic hyaluronic acid for osteoarthritis: efficacy, safety and relation to pre-injection radiographs. Arch Orthop Trauma Surg 127(10):899–903CrossRefPubMed
24.
Migliore A, Tormenta S, Martin LSM et al (2005) Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis. Clin Rheumatol 24:285–289CrossRefPubMed
25.
Tikiz C, Unlu Z, Sener A et al (2005) Comparison of efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis. Clin Rheumatol 24:244–250CrossRefPubMed
26.
Migliore A, Martin LS, Alimonti A, Valente C, Tormenta S (2003) Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis Cartilage 11:305–306CrossRefPubMed
27.
Migliore A, Tormenta S, Massafra U, Bizzi E, Iannessi F, Alimonti A, Granata M (2008) Intra-articular administration of hylan G-F 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice. Curr Med Res Opin 24(5):1309–1316CrossRefPubMed
28.
Migliore A, Tormenta S, Massafra U, Carloni E, Padalino C, Iannessi F, Alimonti A, Martin LS, Granata M (2005) Repeated ultrasound-guided intra-articular injections of 40 mg of Hyalgan may be useful in symptomatic relief of hip osteoarthritis. Osteoarthritis Cartilage 13:1126–1127CrossRefPubMed
29.
Migliore A, Tormenta S, Martin LS, Iannessi F, Massafra U, Carloni E, Monno D, Alimonti A, Granata M (2006) The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up. Clin.Rheumatol 25:389–393CrossRefPubMed
30.
Migliore A, Tormenta S, Massafra U, Martin Martin LS, Carloni E, Padalino C, Alimonti A, Granata M (2006) 18-month observational study on efficacy of intraarticular hyaluronic acid (Hylan G-F 20) injections under ultrasound guidance in hip osteoarthritis. Reumatismo 58:39–49PubMed
31.
Labbe M, Ridgeland E, Savoie FH et al (2003) The short-term efficacy of hyaluronic acid injections for the treatment of degenerative arthrosis of the shoulder. Arthroscopy 19:S13–S18CrossRef
32.
33.
Clarke S, Lock V, Duddy J et al (2005) Intra-articular hylan G-F 20 in the management of patellofemoral osteoarthritis of the knee. Knee 12:57–62CrossRefPubMed
34.
Roux C, Fontas E, Breuil V et al (2007) Injection of intra-articular sodium hyaluronidate (sinovial) into the carpometacarpal joint of the thumb (CMC1) in osteoarthritis. A prospective evaluation of efficacy. Joint Bone Spine 74(4):368–372CrossRefPubMed
35.
Pelletier JP, Martel-Pelletier J (1993) The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation. J Rheumatol Suppl 39:19–24PubMed
36.
Weiss C, Band P (1995) Musculoskeletal applications of hyaluronan and hylan. Potential uses in the foot and ankle. Clin Podiatr Med Surg 12:497–517PubMed
37.
Witteveen A, Giannini S, Guido G, Jerosch J, Lohrer H, Vannini F, Donati F, Schulz A, Scholl J, Sierevelt I, van Dijk N (2008) A prospective multi-centre, open study of the safety and efficacy of hylan G-F 20 (Synvisc®) in patients with symptomatic ankle (talo-crural) osteoarthritis. Foot Ankle Surg 14:145–152CrossRefPubMed
38.
Sun SF, Chou YJ, Hsu CW, Hwang CW, Hsu PT, Wang JL, Hsu YW, Chou MC (2006) Efficacy of intra-articoular hyaluronic acid in patients with osteoarthritis of the ankle: a prospective study. Osteoarthritis Cartilage 14:867–874CrossRefPubMed
39.
Salk RS, Chang TJ, D’Costa WF, Soomekh DJ, Grogan KA (2006) Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double-blind pilot study. J Bone Joint Surg Am 88(2):295–302CrossRefPubMed
40.
Cohen MM, Altman RD, Hollstrom R, Hollstrom C, Sun C, Gipson B (2008) Safety and efficacy of intra-articular sodium hyaluronate (Hyalgan) in a randomized, double-blind study for osteoarthritis of the ankle. Foot Ankle Int 29(7):657–663CrossRefPubMed
41.
Karatosun V, Unver B, Ozden A, Ozay Z, Gunal I (2008) Intra-aticular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long-term follow-up. Clin Exp Rheumatol 26:288–294PubMed
42.
Carpenter B, Motley T (2008) The role of viscosupplementation in the ankle using Hylan GF-20. J Foot Ankle Surg 47(5):377–384CrossRefPubMed
43.
Luciani L, Cadossi M, Tesei F, Chiariello E, Giannini S (2008) Viscosupplementation for grade II osteoarthritis af the ankle: prospective study at 18 months’ follow-up. Chir Organi Mov 92(3):155–160CrossRefPubMed
44.
Domsic RT, Saltzman CL (1998) Ankle osteoarthritis scale. Foot Ankle Int 19(7):466–471PubMed
45.
Kitaoka HB, Alexander IJ, Adelaar RS, Nunley JA, Myerson MS, Sanders M (1994) Clinical rating systems for the ankle–hind-foot, midfoot, hallux and lesser toes. Foot Ankle Int 15:349–353PubMed
46.
Adams ME, Lussier AJ, Peyron JG (2000) A risk-benefit assessment of injections of hyaluronan and its derivate in the treatment of osteoarthritis of the knee. Drug Saf 2:115–130CrossRef
47.
Blaine T, Moskowitz R, Udell J, Skyhar M, Levin R, Friedlander J, Daley M, Altman R (2008) Treatment of persistent shoulder pain with sodium hyaluronate: a randomized, controlled trial. A multicenter study. J Bone Joint Surg Am 90(5):9–979CrossRef
48.
Silverstein E, Leger R, Shea KP (2007) The use of inta-articular Hylan GF-20 in the treatment of symptomatic osteoarthritis of the shoulder: a preliminary study. Am J Sports Med 35(6):979–985CrossRefPubMed
49.
Figen Ayhan F, Ustün N (2009) The evaluation of efficacy and tolerability of Hylan GF-20 in bilateral thumb base osteoarthritis: 6 months follow-up. Clin Rheumatol 28(5):535–541CrossRefPubMed
50.
Moran SL, Duymaz A, Karabekmez FE (2009) The efficacy of hyaluronic acid in the treatment of osteoarthritis of the trapeziometacarpal joint. J Hand Surg Am 34(5):942–944CrossRefPubMed
51.
Salini V, De Amicis D, Abate M, Natale MA, Di Iorio A (2009) Ultrasound-guided hyaluronic acid injection in carpometacarpal osteoarthritis: short-term results. Int J Immunopathol Pharmacol 22(2):455–460PubMed
Metadata
Title
Viscosupplementation in the management of ankle osteoarthritis: a review
Authors
Alberto Migliore
Francesca Giovannangeli
Emanuele Bizzi
Umberto Massafra
Andrea Alimonti
Bruno Laganà
Andrea Diamanti Picchianti
Valentina Germano
Mauro Granata
Prisco Piscitelli
Publication date
01-01-2011
Publisher
Springer-Verlag
Published in
Archives of Orthopaedic and Trauma Surgery / Issue 1/2011
Print ISSN: 0936-8051
Electronic ISSN: 1434-3916
DOI
https://doi.org/10.1007/s00402-010-1165-5

Other articles of this Issue 1/2011

Archives of Orthopaedic and Trauma Surgery 1/2011 Go to the issue

Orthopaedic Surgery

Biomechanical evaluation of the dynamic radioulnar convergence after ulnar head resection, two soft tissue stabilization methods of the distal ulna and ulnar head prosthesis implantation

Orthopaedic Surgery

Anomalous external jugular vein: clinical concerns in treating clavicle fractures

Trauma Surgery

Management of non-union of humeral fractures with the Stryker T2™ compression nail

Orthopaedic Surgery

Achilles tendon ruptures in diabetic patients

Orthopaedic Surgery

Is upper extremity trauma an independent risk factor for lower extremity venous thromboembolism? An 11-year experience at a Level I trauma center

Hip Arthroplasty

Metal-on-metal hip resurfacing: a critical review